[8]Lohinai Z, Klikovits T, Moldvay J, et al. KRAS-mutation incidence and prognostic value are metastatic site-specific in lung adenocarcinoma: poor prognosis in patients with KRAS mutation and bone metastasis. Sci Rep 2017; 7: 39721. [9]Gong J, Hu S, Shan Q, Qin J, Han N, Xie ...
[10]Simmons CP, Koinis F, Fallon MT, Fearon KC, Bowden J, Solheim TS, et al. Prognosis in advanced lung cancer – a prospective study examining key clinicopathological factors. Lung Cancer 2015; 88: 304-9. doi: 10.1016/j. lungcan.2015.03.020 . [11]Imai H, Kishikawa T, Minemura H...
2024年9月30日,Scientific Reports期刊发表了The impact of family cancer history on tumor metabolism and prognosis in patients with non-small cell lung cancer1,文章探讨了家族癌症史对非小细胞肺癌(NSCLC)患者无病生存期(DFS)、肿瘤代谢...
[21]Zhou T, Zhu S, Xiong Q, et al. Intrathecal chemotherapy combined with systemic therapy in patients with refractory leptomeningeal metastasis of non-small cell lung cancer: a retrospective study[J]. BMC Cancer. 2023 Apr 11;23(1):333...
[3]Inamura K, Yokouchi Y, Kobayashi M, et al. Association of tumor TROP2 expression with prognosis varies among lung cancer subtypes. Oncotarget. 2017 Apr 25;8(17):28725-28735. [4]Girard N, Okamoto I, Lisberg A, et al. Datopotamab Deruxtecan (Dato-DXd) in Patients with Previously...
The invention provides methods for identifying early stage non-small cell lung cancer (NSCLC) patients who will have a favorable prognosis for the recurrence of lung cancer after surgical resection. The invention is based on the discovery that assessment of chromosomal copy number abnormalities at ...
[1]Alamri S, Badah MZ, Zorgi S, et al. B. Disease prognosis and therapeutic strategies in patients with advanced non-small cell lung cancer (NSCLC): a 6-year epidemiological study between 2015-2021. Transl Cancer Res. 2024 Feb 29;13(2):762-770. doi: 10.21037/tcr-23-1816. Epub 20...
因此,在进行楔形切除术时,外科医生必须确保切除边缘的距离大于肿瘤浸润部分的大小。进一步的研究,包括来自更大队列的数据和前瞻性随机对照试验,可能会验证这些结论,并提供更多完善的结果。 原文题目:Prognosis after wedge resection in patients with 8thedition TNMstage IA1 and IA2 non-small cell lung cancer...
14. Rosen JM, Jordan CT. The increasing complexity of the cancer stem cell paradigm. Science 2009;324:1670-3. 15. Hobeika C, Rached G, Eid R, et al. ALK-rearranged adenocarcinoma transformed to small-cell lung cancer: a new entity with specific prognosis and treatment? Per Med 2018;15...
of epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI) failure modes in advanced non-small-cell lung cancer (NSCLC). This study aimed to classify the diversity of EGFR-TKI failure, and to investigate the usefulness of clinical modes in subsequent management and prognosis. ...